| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 196,094 shares worth roughly $15.4M.
Classified under Biotechnology (Health Care sector), IONS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 156.0K | $8.82M | - | |
| CEO | 99.9K | $5.65M | - | |
| CFO | 82.7K | $4.68M | - | |
| VP | 74.4K | $4.21M | - | |
| VP | 69.7K | $3.94M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | Geary Richard S65 | EVP, Chief Development Officer | Sale+OE | 7,338 | $50.42 | $369,959.95 | -7.9% | -19.0% | -37.1% | |
| Jan 17, 2024 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 6,745 | $50.42 | $340,062.67 | -8.0% | -19.0% | -37.1% | |
| Jan 17, 2024 | Baroldi Joseph53 | EVP, Chief Business Officer | Sale+OE | 2,024 | $50.42 | $102,044.01 | -12.3% | -19.0% | -37.1% | |
| Jan 17, 2024 | Hougen Elizabeth L55 | EVP, Finance &CFO | Sale+OE | 8,683 | $50.42 | $437,770.81 | -8.7% | -19.0% | -37.1% | |
| Jan 12, 2024 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 8,000 | $53.50 | $427,999.20 | -17.3% | -20.6% | -37.5% | |
| Dec 28, 2023 | Swayze Eric63 | EVP Research | Sale+OE | 27,100 | $50.19 | $1,360,081.25 | -45.5% | -11.6% | -28.9% | |
| Dec 28, 2023 | Parshall B Lynne74 | Director | Sale+OE | 117,638 | $50.48 | $5,938,128.76 | -32.2% | -11.6% | -28.9% | |
| Dec 26, 2023 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 20,825 | $51.46 | $1,071,716.98 | -34.0% | -14.4% | -29.2% | |
| Dec 26, 2023 | Schneider Eugene64 | EVP, Chf Clinical Develop Ofcr | Sale+OE | 25,000 | $51.46 | $1,286,575.00 | -40.9% | -14.4% | -29.2% | |
| Dec 21, 2023 | Bennett C Frank64 | EVP, Chief Scientific Officer | Sale+OE | 22,613 | $49.39 | $1,116,854.48 | -14.7% | -12.9% | -27.4% |